Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1986 2
1987 2
1988 1
1989 3
1990 2
1991 6
1992 4
1993 13
1994 11
1995 9
1996 15
1997 19
1998 8
1999 12
2000 6
2001 12
2002 5
2003 14
2004 21
2005 24
2006 21
2007 12
2008 14
2009 10
2010 17
2011 42
2012 59
2013 34
2014 31
2015 28
2016 33
2017 27
2018 29
2019 24
2020 28
2021 21
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

551 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Trials of Stem Cell Treatment for Spinal Cord Injury.
Yamazaki K, Kawabori M, Seki T, Houkin K. Yamazaki K, et al. Among authors: houkin k. Int J Mol Sci. 2020 Jun 2;21(11):3994. doi: 10.3390/ijms21113994. Int J Mol Sci. 2020. PMID: 32498423 Free PMC article. Review.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Among authors: houkin k. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K; CSPS.com Trial Investigators. Toyoda K, et al. Among authors: houkin k. Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6. Lancet Neurol. 2019. PMID: 31122494 Clinical Trial.
Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K, Osanai T, Uchiyama S, Minematsu K, Taguchi A, Maruichi K, Niiya Y, Asaoka K, Kuga Y, Takizawa K, Haraguchi K, Yoshimura S, Kimura K, Tokunaga K, Aoyama A, Ikawa F, Inenaga C, Abe T, Tominaga A, Takahashi S, Kudo K, Fujimura M, Sugiyama T, Ito M, Kawabori M, Hess DC, Savitz SI, Hirano T; TREASURE Study Investigators. Houkin K, et al. JAMA Neurol. 2024 Feb 1;81(2):154-162. doi: 10.1001/jamaneurol.2023.5200. JAMA Neurol. 2024. PMID: 38227308 Free PMC article. Clinical Trial.
Suprasellar hemangioblastoma.
Miyata S, Mikami T, Minamida Y, Akiyama Y, Houkin K. Miyata S, et al. Among authors: houkin k. J Neuroophthalmol. 2008 Dec;28(4):325-6. doi: 10.1097/WNO.0b013e318183c633. J Neuroophthalmol. 2008. PMID: 19145134
Usefulness of FMISO-PET for glioma analysis.
Kobayashi H, Hirata K, Yamaguchi S, Terasaka S, Shiga T, Houkin K. Kobayashi H, et al. Among authors: houkin k. Neurol Med Chir (Tokyo). 2013;53(11):773-8. doi: 10.2176/nmc.ra2013-0256. Epub 2013 Oct 29. Neurol Med Chir (Tokyo). 2013. PMID: 24172591 Free PMC article. Review.
Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.
Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction. Houkin K, et al. Stroke. 2018 Apr;49(4):e145-e152. doi: 10.1161/STROKEAHA.117.019216. Epub 2018 Mar 16. Stroke. 2018. PMID: 29581346 Review. No abstract available.
The Japan Neurosurgical Database: Overview and Results of the First-year Survey.
Iihara K, Tominaga T, Saito N, Suzuki M, Date I, Fujii Y, Hongo K, Houkin K, Kato A, Kato Y, Kawamata T, Kim P, Kinouchi H, Kohmura E, Kurisu K, Maruyama K, Mikuni N, Miyamoto S, Morita A, Nakase H, Narita Y, Nishikawa R, Nozaki K, Ogasawara K, Ohata K, Sakai N, Sakamoto H, Shiokawa Y, Sonoda Y, Takahashi JC, Ueki K, Wakabayashi T, Yamamoto T, Yoshida K, Kayama T, Arai H; Japan Neurosurgical Society. Iihara K, et al. Among authors: houkin k. Neurol Med Chir (Tokyo). 2020 Apr 15;60(4):165-190. doi: 10.2176/nmc.st.2019-0211. Epub 2020 Mar 31. Neurol Med Chir (Tokyo). 2020. PMID: 32238620 Free PMC article. Review.
551 results